Truist Securities Reiterates Buy on Cargo Therapeutics, Lowers Price Target to $32
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has reiterated its Buy rating on Cargo Therapeutics (NASDAQ:CRGX) but has lowered the price target from $34 to $32.
May 16, 2024 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities has reiterated its Buy rating on Cargo Therapeutics but has lowered the price target from $34 to $32. This indicates continued confidence in the stock despite a slight reduction in expected value.
The Buy rating suggests that Truist Securities still sees potential in Cargo Therapeutics, although the lowered price target indicates a slightly more conservative outlook. This mixed signal may lead to a modest positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100